← Leaderboards
Daniel A Nation
University Of Southern California
$9,985,552
Attributed
$15,006,013
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,006,013 · 6
By mechanism
R01$11,229,585 · 3
R44$2,584,232 · 1
P01$738,446 · 1
R21$453,750 · 1
Top collaborators
- Mark W Bondi3 shared
- Mara Mather3 shared
- Mark Ettenhofer2 shared
- Sarka Olivera Southern2 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Smita Bhatia$27,398,641
- Danny Jiong Jiong Wang$29,986,445
- John C Wood$11,655,933
- Amir H Kashani$11,509,148
- Hussein N Yassine$19,354,869
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseCognitiveLongitudinal StudiesImpaired CognitionDementiaNeuropsychologyBlood VesselsCerebrovascularMagnetic Resonance ImagingLinkElderlyCognitionCerebrumBrainParticipantExhibitsInnovationRisk AssessmentCerebral AtrophyDementia RiskBiological MarkersCellsCognitive Function
Grant awards (21)
Locus Coeruleus Imaging Markers in Preclinical Alzheimers disease, Cerebrovascular Disease and Cognitive Decline$1,607,325
R01 · FY2025 · AG · contact PI
Endothelial progenitor cells and neurovascular injury in the aging$649,365
R01 · FY2025 · AG · contact PI
Locus Coeruleus Imaging Markers in Preclinical Alzheimers disease, Cerebrovascular Disease and Cognitive Decline$1,715,157
R01 · FY2024 · AG · contact PI
Locus Coeruleus Imaging Markers in Preclinical Alzheimers disease, Cerebrovascular Disease and Cognitive Decline$1,623,978
R01 · FY2023 · AG · contact PI
Rapid saliva test for noninvasive diagnostic screening of MCI and dementia$1,302,154
R44 · FY2023 · AG
Project 1 - Biomarkers of Neurovascular Function$738,446
P01 · FY2023 · AG · contact PI
Endothelial progenitor cells and neurovascular injury in the aging brain$633,126
R01 · FY2023 · AG · contact PI
Cerebrovascular resistance in cognitive aging and Alzheimer's disease risk$494,995
R01 · FY2023 · AG · contact PI
Endothelial progenitor cells and neurovascular injury in the aging brain$1
R01 · FY2023 · AG · contact PI
Cerebrovascular resistance in cognitive aging and Alzheimer's disease risk$1
R01 · FY2023 · AG · contact PI
Rapid saliva test for noninvasive diagnostic screening of MCI and dementia$1,282,078
R44 · FY2022 · AG
Endothelial progenitor cells and neurovascular injury in the aging brain$631,612
R01 · FY2022 · AG · contact PI
Cerebrovascular resistance in cognitive aging and Alzheimer's disease risk$491,520
R01 · FY2022 · AG · contact PI
Endothelial progenitor cells and neurovascular injury in the aging brain$690,060
R01 · FY2021 · AG · contact PI
Cerebrovascular resistance in cognitive aging and Alzheimer's disease risk$487,777
R01 · FY2021 · AG · contact PI
Endothelial progenitor cells and neurovascular injury in the aging brain$641,654
R01 · FY2020 · AG · contact PI
Cerebrovascular resistance in cognitive aging and Alzheimer's disease risk$489,891
R01 · FY2020 · AG · contact PI
Cerebrovascular resistance in cognitive aging and Alzheimer's disease risk$449,769
R01 · FY2020 · AG · contact PI
Endothelial progenitor cells and neurovascular injury in the aging brain$623,354
R01 · FY2019 · AG · contact PI
Vascular Reserve and Protective Mechanisms in Aging and Alzheimerâs Dementia Risk$247,500
R21 · FY2018 · AG · contact PI
Vascular Reserve and Protective Mechanisms in Aging and Alzheimerâs Dementia Risk$206,250
R21 · FY2017 · AG · contact PI